报价延迟最少15分钟:2026/09/03 11:10 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
128.67 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.23/-0.50
|
|
企业价值
8.69B
|
| 资产负债 |
|
每股账面净值
6.77
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
376.57M
|
|
每股收益
3.58
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA onsilicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas. |
